Skip to main content
. Author manuscript; available in PMC: 2013 Jan 29.
Published in final edited form as: Leuk Lymphoma. 2010 Feb;51(2):243–251. doi: 10.3109/10428190903480728

Table 1.

Patient demographics and disease characteristics

Induction strategy
Variable Chemotherapy (n=114) Novel agent (n=110)
Patients:
Age, years, mean (SD) 56 (9) 55 (9)
Female, % 42 41
KPS, median: 90 90
Diagnosis to SCT, d, mean (SD) 232 (53) 110 (82)
Disease:
ISS stage, med: 2 2
Durie-Salmon stage, %:
 1: 9 10
 2: 16 13
 3: 77 77
Isotype, %:
 IgG: 58 51
 IgA: 24 23
 Light chain only: 13 25
 IgD:   5   1
Cytogenetics,%:
 Standard risk: 74 74
 High risk: 26 26
Radiation, %: 22 18